• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

No evidence supports the use of ether and chloroform inhalation for treating COVID-19

 
Thumbnail
Date
2020-03
Author
Martins-Filho, Paulo Ricardo Santos
Santos, Victor Santana
Metadata
Show full item record
Abstract
Dear Editor, SARS-CoV-2 has been spreading rapidly across the world as well as the number of fake news on social media regarding harmful or non-harmful treatments which are ineffective for treating COVID-19. In Brazil, the first case of COVID-19 was confirmed on February 26, 2020 and until March 20, 2020 at least 970 cases and seven deaths have been reported. The fear and uncertainty have led people to consume and share mistrust and misinformation on the Internet. Since the first confirmed case in Brazil, fake news about the effectiveness of an ether and chloroform blend known as “lança perfume” or “loló” were spread on social media. Nowadays, the ecosystem of big data has provided valuable information about online health-related behaviour and new patterns among population groups using social media data. Google Trends may act as an efficient real time surveillance system by monitoring hit searches of specific health issues leading to reliable and meaningful indicators to track health information demand and supply trends. We used Google Trends to assess recent search activity (from February 25 to March 20, 2020) on the novel coronavirus in Brazil and the popularity of related search terms. Related searches for coronavirus revealed a high level of interest (a breakout over 5000%) on the information about the use of an ether and chloroform blend in treating COVID-19, especially in the North and Northeast regions which are recognized as the poorest regions in the country.
URI
https://doi.org/10.26633/RPSP.2020.41
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)